UBC’s world class expertise in Life Sciences, cutting edge equipment, strong clinical integration, flexible IP policies and low overhead create an attractive value proposition and foster numerous industrial collaborations. LSI researchers are working with both local and global industrial partners and over 80 of the Institute's technologies have been successfully commercialized. LSI researchers have founded over 20 companies with diverse products and technologies in cancer and viral infection care, environmental drug discovery, and immunotherapy for treatment of several prevalent, chronic diseases including IBD and diabetes.
A leading centre of excellence in the development and application of high-throughput methods to a variety of biological systems, as well as in the training of the next generation of researchers. The Centre’s research benefits health care, pharmaceutical, agriculture, forestry and alternative energy industries, and its researchers have generated in excess of 65 patents, licensed in excess of 10 technologies, moved 2 drug candidates through pre-clinical phases, and created spin-off companies.
Regroups scientists from UBC, Vancouver General Hospital and the BC Centre for Disease Control to understand how drug resistant strains of Mycobacterium tuberculosis infects and establishes itself in humans — key to the development of effective new drugs against the bacterium.
PCF has been providing mass spectrometry and proteomic services to Lower Mainland research labs including universities, non-profit organizations, hospitals, and biotechnology corporations for over a decade. Specializing in characterizing post translational modifications and quantitative proteomics, the facility can provide comprehensive analysis for a broad range of proteomics projects using the latest techniques.
Part of UBC’s Michael Smith Laboratories, the centre provides academic scientists and biotechnology corporations access to and training on a suite of high-precision instruments for biophysical measurements. It is the only such service available in Canada. The centre includes high sensitivity isothermal titration calorimeters, differential scanning calorimeters, and a Biacore surface plasmon resonance detector.
Provides a focal point for faculty and graduate students who develop and disseminate methods for data analysis in the health and life sciences. Activities include methodological research, collaborative research, consultation, and support and service to the broader biostatistical community. The group co-operates with related agencies and efforts: clinical trials and health promotion centres, the BC Ministry of Health, the BC Cancer Agency and other clinical research organizations and the Canadian Society for Epidemiology and Biostatistics.
- Anandia Labs
- Aspect Biosystems
- Microbiome Insights
- Anandia Labs
- 3Ci Inc
- KMH Pharmaceuticals
- TerraGen Discovery
- QLT Inc.
- Prescient NeuroPharma Inc. (Note: formerly IGT Pharma)
- Aurora Biomed
- Immune Network Ltd.
- Biomarin Pharmaceutical Inc. (Note: formerly Synapse Technologies)
- Migenix Inc. (Note: formerly know as Micrologix Biotech Inc.)
- NeuroMed Technologies Inc.
- NeuroVir Therapeutics Inc. (Note: acquired by MediGene)
- Point Grey Research Inc.
- Raven Biotech Inc.
- TapImmune (Note: formerly GeneMax Pharmaceuticals Inc.)
- Inimex Pharmaceuticals Inc.
- Network Immunology Inc. (Note: formerly Hoffmann Technologies Inc.)
- Aquinox Pharmaceuticals Inc.
- Boreal Genomics
- BioAMPS International
- Precision Nanosystems
- bioMmune Technologies